Mahashabde; Shashank
Patent Applications and Registrations
Patent applications and USPTO patent grants for Mahashabde; Shashank.The latest application filed is for "modified release formulations of memantine oral dosage forms".
- Mahashabde; Shashank - Kendall Park NJ
- MAHASHABDE; Shashank - Pomona NY
- Mahashabde; Shashank - Kendell Park NJ
| Patent | Date |
|---|---|
| Modified Release Formulations Of Memantine Oral Dosage Forms App 20200268685 - Rastogi; Suneel K. ; et al. | 2020-08-27 |
| Modified release formulations of memantine oral dosage forms Grant 10,660,868 - Rastogi , et al. | 2020-05-26 |
| Orally Dissolving Formulations Of Memantine App 20170172942 - Mahashabde; Shashank ; et al. | 2017-06-22 |
| Modified Release Formulations Of Memantine Oral Dosage Forms App 20160324803 - Rastogi; Suneel K. ; et al. | 2016-11-10 |
| Modified Release Formulations Of Memantine Oral Dosage Forms App 20150258031 - RASTOGI; Suneel K. ; et al. | 2015-09-17 |
| Orally Dissolving Formulations of Memantine App 20150238442 - Mahashabde; Shashank ; et al. | 2015-08-27 |
| Modified Release Formulations Of Memantine Oral Dosage Forms App 20150148427 - RASTOGI; Suneel K. ; et al. | 2015-05-28 |
| Orally Dissolving Formulations of Memantine App 20150065582 - Mahashabde; Shashank ; et al. | 2015-03-05 |
| Compositions Comprising Cyclohexylamines And Aminoadamantanes App 20140350114 - DEDHIYA; Mahendra G. ; et al. | 2014-11-27 |
| Modified Release Formulations Of Memantine Oral Dosage Forms App 20140213659 - RASTOGI; Suneel K. ; et al. | 2014-07-31 |
| Modified Release Formulations Of Memantine Oral Dosage Forms App 20130310460 - RASTOGI; Suneel K. ; et al. | 2013-11-21 |
| Modified Release Formulations Of Memantine Oral Dosage Forms App 20130012593 - Rastogi; Suneel K. ; et al. | 2013-01-10 |
| Compositions Comprising Cyclohexylamines And Aminoadamantanes App 20120238631 - Dedhiya; Mahendra G. ; et al. | 2012-09-20 |
| Antifungal composition with enhanced bioavailability Grant 8,263,600 - Sharpe , et al. September 11, 2 | 2012-09-11 |
| Modified Release Formulations Of Memantine Oral Dosage Forms App 20120004318 - Rastogi; Suneel K. ; et al. | 2012-01-05 |
| Modified release formulations of memantine oral dosage forms Grant 8,039,009 - Rastogi , et al. October 18, 2 | 2011-10-18 |
| Antifungal Composition With Enhanced Bioavailability App 20110244004 - Sharpe; Stefan ; et al. | 2011-10-06 |
| Orally Dissolving Formulations of Memantine App 20110046232 - Mahashabde; Shashank ; et al. | 2011-02-24 |
| Compositions comprising Cyclohexylamines and Aminoadamantanes App 20100035995 - Dedhiya; Mahendra G. ; et al. | 2010-02-11 |
| Crystalline Composition Containing Escitalopram App 20080305164 - Christensen; Troels Volsgaard ; et al. | 2008-12-11 |
| Crystalline composition containing escitalopram Grant 7,420,069 - Christensen , et al. September 2, 2 | 2008-09-02 |
| Compositions Comprising Cyclohexylamines and Aminoadamantanes App 20070270500 - Dedhiya; Mahendra G. ; et al. | 2007-11-22 |
| Modified release formulations of memantine oral dosage forms App 20060051416 - Rastogi; Suneel K. ; et al. | 2006-03-09 |
| Crystalline composition containing escitalopram Grant 6,916,941 - Christensen , et al. July 12, 2 | 2005-07-12 |
| Crystalline composition containing escitalopram App 20050147674 - Christensen, Troels Volsgaard ; et al. | 2005-07-07 |
| Crystalline composition containing escitalopram App 20030212128 - Christensen, Troels Volsgaard ; et al. | 2003-11-13 |
| Antifungal composition with enhanced bioavailability App 20030055067 - Sharpe, Stefan ; et al. | 2003-03-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 